Proximyl Health


CIN Snake Disease Awareness Campaign


Chemotherapy-induced neutropenia (CIN) is a major problem for patients in chemotherapy. The dangers of neutropenia are so great, oncologists are often forced to alter or pause their treatment, leaving patients at grave risk. Many oncologists feel this is a necessary evil of chemotherapy and will manage neutropenia when it occurs. But COVID-19 has escalated the situation, leaving cancer patients unprotected with reduced neutrophil levels, and at even greater risk of infection, extended hospitalizations, and life-threatening events.


Make them uncomfortable. In partnership with our clients at BeyondSpring, we created a disease awareness campaign so powerful, arresting, and even frightening that it simply could not be ignored. We let oncologists know that BeyondSpring is relentless in their pursuit to deliver ground-breaking solutions for real-world patients trying to survive cancer in a COVID-19 world.

Proximyl Health Team:
Tina Fascetti, Managing Director/Chief Creative Officer
Halen Van Dang, VP, Creative Director, Art
Glenn Hauler, Creative Director, Copy
Ron Kellow, Associate Creative Director, Copy
Amber Pavlou, Group Art Supervisor
Michelle Leung, Art Director
Aron Brand, Lead Motion Designer
Kevin Stone, SVP, Account Director
Emmy Marr, Senior Account Executive
Amy Anderson, Senior Project Manager
Rachel Seidman, Director, Digital Strategy
Mario Abbate, Director, Development

Production Team:

BeyondSpring Team:
Lan Huang, PhD, CEO
Rich Daly, Chief Operating Officer
Paul Friel, Chief Commercial Officer


You May Also Like

My Other Life with Don Abramo

PM360 recently spoke to Don Abramo, Sr. Director of Marketing at Pharming, about mastering ...

PM360 2021 Trailblazer Awards Marketing Team of the Year Silver Winner ORLADEYO Brand Team

ORLADEYO Brand Team BioCryst Pharmaceuticals Team Members: Frank Nazzario, Vice President, U.S. Marketing Danielle ...

Resolving a Critical Paradox

Healthcare is a complex industry—one that is feeling the impacts of the global pandemic ...